Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miner, T. J.
Right arrow Articles by Krag, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miner, T. J.
Right arrow Articles by Krag, D. N.

Annals of Surgical Oncology, Vol 6, Issue 1 75-82, Copyright © 1999 by Society of Surgical Oncology


ARTICLES

Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node

T. J. Miner, C. D. Shriver, P. R. Flicek, F. C. Miner, D. P. Jaques, M. E. Maniscalco-Theberge and D. N. Krag
General Surgery Service, Walter Reed Army Medical Center, Washington, DC 20307, USA.

BACKGROUND: Several reports have demonstrated accurate prediction of nodal metastasis with radiolocalization and selective resection of the radiolocalized sentinel lymph node (SLN) in patients with breast cancer and melanoma. As reliance on this technique grows, its use by those without experience in radiation safety will increase. METHODS: Tissue obtained during radioguided SLN biopsies was examined for residual radioactivity. Specimens with a specific activity greater than the radiologic control level (RCL) of 0.002 microCi/g were considered radioactive. Radiation exposure to the surgical team was measured. RESULTS: A total of 24 primary tissue specimens and 318 lymph nodes were obtained during 57 operations (37 for breast cancer, 20 for melanoma). All 24 (100%) of the specimens injected with radiopharmaceutical and 89 of 98 (91%) of the localized nodes were radioactive after surgery. Activity fell below the RCL 71+/-3.6 hours in primary tissue specimens, 46+/-1.7 hours in nodes from melanoma patients, and 33+/-3.5 hours in nodes from breast cancer patients (P = .037). The hands of the surgical team (n = 22 cases) were exposed to 9.4+/-3.6 mrem/case. CONCLUSION: Although low levels of radiation exposure are associated with radiolocalization and resection of the SLN, the presented guidelines ensure conformity to existing regulations and allow timely pathologic analysis.


This article has been cited by other articles:


Home page
ChestHome page
O. Tiffet, A. G. Nicholson, A. Khaddage, N. Prevot, G. Ladas, F. Dubois, and P. Goldstraw
Feasibility of the Detection of the Sentinel Lymph Node in Peripheral Non-small Cell Lung Cancer With Radio Isotopic and Blue Dye Techniques
Chest, February 1, 2005; 127(2): 443 - 448.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. A. King, J. V. Fey, K. J. Van Zee, A. S. Heerdt, M. L. Gemignani, E. R. Port, L. Sclafani, V. Sacchini, J. A. Petrek, H. S. Cody III, et al.
A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients With Breast Cancer
Ann. Surg. Oncol., May 1, 2004; 11(5): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
J. Gough, M. Anliker, M. E. Spieth, and D. L. Kasner
Parathyroid Adenoma Radiation Dose Simulator
Clin. Med. Res., February 1, 2004; 2(1): 55 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Nakagawa, Y. Minamiya, Y. Katayose, H. Saito, K. Taguchi, H. Imano, H. Watanabe, K. Enomoto, M. Sageshima, T. Ueda, et al.
A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 563 - 567.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
R Morton, P W Horton, D J Peet, and M W Kissin
Quantitative assessment of the radiation hazards and risks in sentinel node procedures
Br. J. Radiol., February 1, 2003; 76(902): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. D. McCarter, H. Yeung, S. Yeh, J. Fey, P. I. Borgen, and H. S. Cody III
Localization of the Sentinel Node in Breast Cancer: Identical Results With Same-Day and Day-Before Isotope Injection
Ann. Surg. Oncol., September 1, 2001; 8(8): 682 - 686.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Mariani, L. Moresco, G. Viale, G. Villa, M. Bagnasco, G. Canavese, J. Buscombe, H. W. Strauss, and G. Paganelli
Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery
J. Nucl. Med., August 1, 2001; 42(8): 1198 - 1215.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
T. J. Colgan, D. Booth, A. Hendler, and D. McCready
Appropriate procedures for the safe handling and pathologic examination of technetium-99m-labelled specimens
Can. Med. Assoc. J., June 1, 2001; 164(13): 1868 - 1871.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A P Toms and K K Balan
The fog clears
Br. J. Radiol., March 1, 2001; 74(879): 295 - 296.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Cserni
Axillary staging of breast cancer and the sentinel node
J. Clin. Pathol., October 1, 2000; 53(10): 733 - 741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.